董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Charles M. Farkas | 男 | Independent Director | 74 | 21.75万美元 | 未持股 | 2025-09-08 |
| Patrick J. Beyer | 男 | Director, President and Chief Executive Officer | 59 | 112.81万美元 | 未持股 | 2025-09-08 |
| David Bronson | 男 | Independent Director | 72 | 21.37万美元 | 未持股 | 2025-09-08 |
| Kim Kelderman | 男 | Independent Director | 58 | 未披露 | 未持股 | 2025-09-08 |
| LaVerne Council | -- | Chair of the Board | -- | 未披露 | 未持股 | 2025-09-08 |
| Mark B. Kaye | -- | Director | -- | 未披露 | 未持股 | 2025-09-08 |
| Kimberly A. Lockwood | -- | Senior Director, Financial Reporting | -- | 未披露 | 未持股 | 2025-09-08 |
| Barbara J. Schwarzentraub | -- | Independent Director | -- | 未披露 | 未持股 | 2025-09-08 |
| Brian Concannon | 男 | Independent Director | 67 | 21.75万美元 | 未持股 | 2025-09-08 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Patrick J. Beyer | 男 | Director, President and Chief Executive Officer | 59 | 112.81万美元 | 未持股 | 2025-09-08 |
| Johonna Pelletier | 女 | Treasurer and Vice President, Tax | 52 | 未披露 | 未持股 | 2025-09-08 |
| Petre K. Shagory | 男 | Executive Vice President, Strategy and Corporate Development | 56 | 未披露 | 未持股 | 2025-09-08 |
| Todd W. Garner | -- | Executive Vice President, Finance and Chief Financial Officer | -- | 未披露 | 未持股 | 2025-09-08 |
| Richard Glaze | -- | Chief Information Officer | -- | 未披露 | 未持股 | 2025-09-08 |
| Stephan Epinette | -- | Vice President and General Manager, International | -- | 未披露 | 未持股 | 2025-09-08 |
| Andrew James Moller | -- | Principal Accounting Officer | -- | 未披露 | 未持股 | 2025-09-08 |
| Hollie K. Foust | -- | Executive Vice President, General Counsel and Corporate Secretary | -- | 未披露 | 未持股 | 2025-09-08 |
| John D. Ferrell | -- | Executive Vice President, Human Resources | -- | 未披露 | 未持股 | 2025-09-08 |
| Edward A. Clifford | -- | Vice President, Global Manufacturing | -- | 未披露 | 未持股 | 2025-09-08 |
| Brent Lalomia | -- | Executive Vice President, Regulatory Affairs, Quality Assurance, Clinical Affairs and Commercial Operations | -- | 未披露 | 未持股 | 2025-09-08 |
| Kimberly A. Lockwood | -- | Senior Director, Financial Reporting | -- | 未披露 | 未持股 | 2025-09-08 |
董事简历
中英对照 | 中文 | 英文- Charles M. Farkas
-
Charles M. Farkas，2014年7月23日起，担任本公司董事。他现为咨询公司Bain & Company的资深合伙人；有着超过35年为各行各业首席执行官、高级经理提供咨询服务的经验，协助他们解决长久成功的关键问题。他曾在Bain & Company担任金融服务业务全球Leader、医疗保健行业北美地区总监、加拿大地区总经理。加入Bain之前，他在Princeton University获得学士学位，在Harvard Business School获得工商管理硕士学位。他目前还是Harvard Medical School的董事、Partners Healthcare的法人之一。本公司已认定他的身份是独立的。
Charles M. Farkas,Advisory Partner at Bain & Company; Director of the Company. As noted below, the Board of Directors has determined that Mr. Farkas is independent. - Charles M. Farkas，2014年7月23日起，担任本公司董事。他现为咨询公司Bain & Company的资深合伙人；有着超过35年为各行各业首席执行官、高级经理提供咨询服务的经验，协助他们解决长久成功的关键问题。他曾在Bain & Company担任金融服务业务全球Leader、医疗保健行业北美地区总监、加拿大地区总经理。加入Bain之前，他在Princeton University获得学士学位，在Harvard Business School获得工商管理硕士学位。他目前还是Harvard Medical School的董事、Partners Healthcare的法人之一。本公司已认定他的身份是独立的。
- Charles M. Farkas,Advisory Partner at Bain & Company; Director of the Company. As noted below, the Board of Directors has determined that Mr. Farkas is independent.
- Patrick J. Beyer
-
Patrick J. Beyer于2014年12月加入公司担任CONMED International总裁。加入CONMED之前，Beyer从2010年到2014年担任ICNet（一家私营感染控制软件公司）首席执行官，公司于2014年被卖掉。在此之前，Beyer在Stryker Corporation任职了21年，2005年到2009年领导Stryker Europe；2002年到2005年领导Stryker UK, South Africa and Ireland；1999年到2002年领导Stryker Medical。Beyer毕业于Kalamazoo College，持有经济学文学学士学位；持有Western Michigan University金融工商管理硕士学位；Harvard Business School高级管理项目毕业生。
Patrick J. Beyer joined the Company as President of CONMED International in December 2014. Prior to joining CONMED, Mr. Beyer served as Chief Executive Officer of ICNet, a privately held infectious control software company from 2010 to 2014 when the company was sold. Prior to this, Mr. Beyer spent 21 years at Stryker Corporation where he led Stryker Europe from 2005-2009; Stryker UK, South Africa and Ireland from 2002 to 2005 and Stryker Medical from 1999 to 2002. Mr. Beyer graduated from Kalamazoo College with a BA in Economics, Western Michigan University with an MBA in Finance and Harvard Business School’s Advanced Management Program. - Patrick J. Beyer于2014年12月加入公司担任CONMED International总裁。加入CONMED之前，Beyer从2010年到2014年担任ICNet（一家私营感染控制软件公司）首席执行官，公司于2014年被卖掉。在此之前，Beyer在Stryker Corporation任职了21年，2005年到2009年领导Stryker Europe；2002年到2005年领导Stryker UK, South Africa and Ireland；1999年到2002年领导Stryker Medical。Beyer毕业于Kalamazoo College，持有经济学文学学士学位；持有Western Michigan University金融工商管理硕士学位；Harvard Business School高级管理项目毕业生。
- Patrick J. Beyer joined the Company as President of CONMED International in December 2014. Prior to joining CONMED, Mr. Beyer served as Chief Executive Officer of ICNet, a privately held infectious control software company from 2010 to 2014 when the company was sold. Prior to this, Mr. Beyer spent 21 years at Stryker Corporation where he led Stryker Europe from 2005-2009; Stryker UK, South Africa and Ireland from 2002 to 2005 and Stryker Medical from 1999 to 2002. Mr. Beyer graduated from Kalamazoo College with a BA in Economics, Western Michigan University with an MBA in Finance and Harvard Business School’s Advanced Management Program.
- David Bronson
-
David Bronson，前执行副总裁兼PSS环球药品，首席财务官，Inc. TERM1；公司董事。
David Bronson,Former Executive Vice President and Chief Financial Officer of PSS World Medical, Inc.; Director of the Company. - David Bronson，前执行副总裁兼PSS环球药品，首席财务官，Inc. TERM1；公司董事。
- David Bronson,Former Executive Vice President and Chief Financial Officer of PSS World Medical, Inc.; Director of the Company.
- Kim Kelderman
-
Kim Kelderman于2018年4月30日加入Bio-Techne，担任诊断和基因组学总裁。在加入Bio-Techne之前，Kelderman先生受雇于Thermo Fisher Scientific，在那里他领导了三个规模和复杂性不断增加的不同业务。在过去三年中，Kelderman先生管理着遗传科学部门的平台和内容，负责仪器、软件、耗材和分析业务，以及应用生物系统和legacy Affymetrix等品牌。在加入Thermo Fisher之前，Kim曾担任Becton Dickinson的高级部门主管，负责管理 global Blood“Vacutainer”业务。
Kim Kelderman,was promoted to President and Chief Executive Officer of the Company on February 1, 2024 and has been an executive officer of the Company since joining the Company in 2018. Prior to joining the Company, he served as an executive at Thermo Fisher Scientific and as a Senior Segment Leader at Becton Dickinson. - Kim Kelderman于2018年4月30日加入Bio-Techne，担任诊断和基因组学总裁。在加入Bio-Techne之前，Kelderman先生受雇于Thermo Fisher Scientific，在那里他领导了三个规模和复杂性不断增加的不同业务。在过去三年中，Kelderman先生管理着遗传科学部门的平台和内容，负责仪器、软件、耗材和分析业务，以及应用生物系统和legacy Affymetrix等品牌。在加入Thermo Fisher之前，Kim曾担任Becton Dickinson的高级部门主管，负责管理 global Blood“Vacutainer”业务。
- Kim Kelderman,was promoted to President and Chief Executive Officer of the Company on February 1, 2024 and has been an executive officer of the Company since joining the Company in 2018. Prior to joining the Company, he served as an executive at Thermo Fisher Scientific and as a Senior Segment Leader at Becton Dickinson.
- LaVerne Council
-
暂无中文简介
暂无英文简介 -
暂无中文简介
- 暂无英文简介
- Mark B. Kaye
-
暂无中文简介
暂无英文简介 -
暂无中文简介
- 暂无英文简介
- Kimberly A. Lockwood
-
暂无中文简介
暂无英文简介 -
暂无中文简介
- 暂无英文简介
- Barbara J. Schwarzentraub
-
暂无中文简介
暂无英文简介 -
暂无中文简介
- 暂无英文简介
- Brian Concannon
-
Brian Concannon在2003年加入Haemonetics担任总裁兼首席执行官并作为Patient Division负责人。他在2006年被提升为Global Markets总裁，然后在2007年担任首席运营官。2009年4月，他被提升为总裁兼首席执行官，并当选为Haemonetics董事会。加入Haemonetics之前，自1998年以来他是 the Northeast Region at Cardinal Health Medical Products and Services的负责人。从1985年到1998年他受雇于 American Hospital Supply Corporation, Baxter Healthcare Corporation和Allegiance Healthcare，随着职业发展担任一系列的销售和运营管理职位。
Brian Concannon,Former President and Chief Executive Officer of Haemonetics Corporation NYSE: HAE; Director of the Company. As noted below, the Board of Directors has determined that Mr. Concannon is independent. - Brian Concannon在2003年加入Haemonetics担任总裁兼首席执行官并作为Patient Division负责人。他在2006年被提升为Global Markets总裁，然后在2007年担任首席运营官。2009年4月，他被提升为总裁兼首席执行官，并当选为Haemonetics董事会。加入Haemonetics之前，自1998年以来他是 the Northeast Region at Cardinal Health Medical Products and Services的负责人。从1985年到1998年他受雇于 American Hospital Supply Corporation, Baxter Healthcare Corporation和Allegiance Healthcare，随着职业发展担任一系列的销售和运营管理职位。
- Brian Concannon,Former President and Chief Executive Officer of Haemonetics Corporation NYSE: HAE; Director of the Company. As noted below, the Board of Directors has determined that Mr. Concannon is independent.
高管简历
中英对照 | 中文 | 英文- Patrick J. Beyer
Patrick J. Beyer于2014年12月加入公司担任CONMED International总裁。加入CONMED之前，Beyer从2010年到2014年担任ICNet（一家私营感染控制软件公司）首席执行官，公司于2014年被卖掉。在此之前，Beyer在Stryker Corporation任职了21年，2005年到2009年领导Stryker Europe；2002年到2005年领导Stryker UK, South Africa and Ireland；1999年到2002年领导Stryker Medical。Beyer毕业于Kalamazoo College，持有经济学文学学士学位；持有Western Michigan University金融工商管理硕士学位；Harvard Business School高级管理项目毕业生。
Patrick J. Beyer joined the Company as President of CONMED International in December 2014. Prior to joining CONMED, Mr. Beyer served as Chief Executive Officer of ICNet, a privately held infectious control software company from 2010 to 2014 when the company was sold. Prior to this, Mr. Beyer spent 21 years at Stryker Corporation where he led Stryker Europe from 2005-2009; Stryker UK, South Africa and Ireland from 2002 to 2005 and Stryker Medical from 1999 to 2002. Mr. Beyer graduated from Kalamazoo College with a BA in Economics, Western Michigan University with an MBA in Finance and Harvard Business School’s Advanced Management Program.- Patrick J. Beyer于2014年12月加入公司担任CONMED International总裁。加入CONMED之前，Beyer从2010年到2014年担任ICNet（一家私营感染控制软件公司）首席执行官，公司于2014年被卖掉。在此之前，Beyer在Stryker Corporation任职了21年，2005年到2009年领导Stryker Europe；2002年到2005年领导Stryker UK, South Africa and Ireland；1999年到2002年领导Stryker Medical。Beyer毕业于Kalamazoo College，持有经济学文学学士学位；持有Western Michigan University金融工商管理硕士学位；Harvard Business School高级管理项目毕业生。
- Patrick J. Beyer joined the Company as President of CONMED International in December 2014. Prior to joining CONMED, Mr. Beyer served as Chief Executive Officer of ICNet, a privately held infectious control software company from 2010 to 2014 when the company was sold. Prior to this, Mr. Beyer spent 21 years at Stryker Corporation where he led Stryker Europe from 2005-2009; Stryker UK, South Africa and Ireland from 2002 to 2005 and Stryker Medical from 1999 to 2002. Mr. Beyer graduated from Kalamazoo College with a BA in Economics, Western Michigan University with an MBA in Finance and Harvard Business School’s Advanced Management Program.
- Johonna Pelletier
Johonna Pelletier于2005年加入公司担任税收主管。Pelletier于2015年4月1日正式成为税收财务主管和副总裁。加入公司之前，她在PricewaterhouseCoopers LLP任职，最近的职位是担任税收高级经理。她是一名注册会计师，毕业于Le Moyne College，持有会计理学学士学位。
Johonna Pelletier joined the Company in 2005 as Tax Director. Effective April 1 2015 Ms. Pelletier was promoted to Treasurer and Vice President, Tax. Prior to joining the Company, she was employed by PricewaterhouseCoopers LLP where she most recently served as a tax senior manager. She is a certified public accountant and graduated with a B.S. degree in Accounting from Le Moyne College.- Johonna Pelletier于2005年加入公司担任税收主管。Pelletier于2015年4月1日正式成为税收财务主管和副总裁。加入公司之前，她在PricewaterhouseCoopers LLP任职，最近的职位是担任税收高级经理。她是一名注册会计师，毕业于Le Moyne College，持有会计理学学士学位。
- Johonna Pelletier joined the Company in 2005 as Tax Director. Effective April 1 2015 Ms. Pelletier was promoted to Treasurer and Vice President, Tax. Prior to joining the Company, she was employed by PricewaterhouseCoopers LLP where she most recently served as a tax senior manager. She is a certified public accountant and graduated with a B.S. degree in Accounting from Le Moyne College.
- Petre K. Shagory
Petre K. Shagory于2015年5月加入本公司担任战略和企业发展执行副总裁。Shagory先生在过去的风险投资，投资银行和公司职务方面拥有超过20年的医疗风险投资和并购经验 。 在加入CONMED之前，Shagory先生在2013年6月至2015年5月领导Cardinal Health’s Medical Products Group在医学部门的战略和业务发展工作，他在Cardinal Health介入性心血管和高级伤口护理类别扮演着重要的职务。 在此之前，Shagory先生于2004年1月至2013年年中负责Baird Venture Partners医疗保健和生命科学投资工作，专注于医疗技术和研究工具和诊断。 Shagory先生从Dartmouth’s Tuck School of Business 获得工商管理硕士学位，并在俄亥俄州牛津的Miami University获得金融学士学位。
Petre K. Shagory joined the Company as Executive Vice President, Strategy and Corporate Development in May 2015. Mr. Shagory has more than 20 years of experience in healthcare venture investing and mergers and acquisitions through his previous venture capital, investment banking and corporate roles. Prior to joining CONMED, from June 2013 to May 2015 Mr. Shagory was employed in the strategy and business development group for Cardinal Health’s Medical Products Group within the Medical Segment, where he played a key role in Cardinal Health’s entry into the interventional cardiovascular and the advanced wound care categories. Prior to that, Mr. Shagory led the healthcare and life sciences investment effort at Baird Venture Partners from January 2004 to mid-2013 focusing on medical technology and research tools and diagnostics. Mr. Shagory earned an MBA from Dartmouth’s Tuck School of Business and a B.S. in Finance from Miami University in Oxford, Ohio.- Petre K. Shagory于2015年5月加入本公司担任战略和企业发展执行副总裁。Shagory先生在过去的风险投资，投资银行和公司职务方面拥有超过20年的医疗风险投资和并购经验 。 在加入CONMED之前，Shagory先生在2013年6月至2015年5月领导Cardinal Health’s Medical Products Group在医学部门的战略和业务发展工作，他在Cardinal Health介入性心血管和高级伤口护理类别扮演着重要的职务。 在此之前，Shagory先生于2004年1月至2013年年中负责Baird Venture Partners医疗保健和生命科学投资工作，专注于医疗技术和研究工具和诊断。 Shagory先生从Dartmouth’s Tuck School of Business 获得工商管理硕士学位，并在俄亥俄州牛津的Miami University获得金融学士学位。
- Petre K. Shagory joined the Company as Executive Vice President, Strategy and Corporate Development in May 2015. Mr. Shagory has more than 20 years of experience in healthcare venture investing and mergers and acquisitions through his previous venture capital, investment banking and corporate roles. Prior to joining CONMED, from June 2013 to May 2015 Mr. Shagory was employed in the strategy and business development group for Cardinal Health’s Medical Products Group within the Medical Segment, where he played a key role in Cardinal Health’s entry into the interventional cardiovascular and the advanced wound care categories. Prior to that, Mr. Shagory led the healthcare and life sciences investment effort at Baird Venture Partners from January 2004 to mid-2013 focusing on medical technology and research tools and diagnostics. Mr. Shagory earned an MBA from Dartmouth’s Tuck School of Business and a B.S. in Finance from Miami University in Oxford, Ohio.
- Todd W. Garner
- 暂无中文简介
暂无英文简介 - 暂无中文简介
- 暂无英文简介
- Richard Glaze
- 暂无中文简介
暂无英文简介 - 暂无中文简介
- 暂无英文简介
- Stephan Epinette
- 暂无中文简介
暂无英文简介 - 暂无中文简介
- 暂无英文简介
- Andrew James Moller
- 暂无中文简介
暂无英文简介 - 暂无中文简介
- 暂无英文简介
- Hollie K. Foust
- 暂无中文简介
暂无英文简介 - 暂无中文简介
- 暂无英文简介
- John D. Ferrell
- 暂无中文简介
暂无英文简介 - 暂无中文简介
- 暂无英文简介
- Edward A. Clifford
- 暂无中文简介
暂无英文简介 - 暂无中文简介
- 暂无英文简介
- Brent Lalomia
- 暂无中文简介
暂无英文简介 - 暂无中文简介
- 暂无英文简介
- Kimberly A. Lockwood
- 暂无中文简介
暂无英文简介 - 暂无中文简介
- 暂无英文简介